NSE ScannerTrading & Distribution · Wholesale Distributors · NSE: VIKASLIFE · data 2026-10-31
Vikas Lifecare Limited
In plain words
Price: 46.9% below its 52-week high of ₹2.09.
Delivery: 52.2% of traded shares were kept for delivery over the last 10 sessions, against 56.4% over the last 60.
Latest results: a net loss of ₹3 cr for the quarter ended Mar 2025.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹499 cr |
| Net profit (last 12 months) | ₹-111 cr |
| Sales growth, 3 years (yearly) | 1.6% |
| Profit growth, 3 years (yearly) | — |
At a glance
Promoters 14.2%, pledged 0.0%, institutions 0.3%.
ROE 3.4%, ROCE -9.2%, operating margin -10.9%: how much profit it earns on the money it uses.
Debt/equity 0.19, Profit growth — and sales growth 1.6% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (3.4%).
- Thin operating margin (-10.9%).
- Slow sales growth (1.6% a year over 3 years).
- Promoters have pledged 0.0% of their shares.
- Reported a loss in the latest quarter.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q4 FY25)
VIKASLIFE Q4 FY25 results (consolidated figures, as filed on NSE).
Revenue was ₹135.2 crore.
Net loss was ₹2.82 crore.
Operating margin was 14.5%.
EPS was -₹0.02.
VIKASLIFE के Q4 FY25 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹135.2 करोड़।
शुद्ध घाटा: ₹2.82 करोड़।
ऑपरेटिंग मार्जिन: 14.5%।
EPS: -₹0.02।
VIKASLIFEના Q4 FY25 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹135.2 કરોડ.
ચોખ્ખી ખોટ: ₹2.82 કરોડ.
ઓપરેટિંગ માર્જિન: 14.5%.
EPS: -₹0.02.
Written from the filed numbers. Not a recommendation.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 52.6% over the last 20 sessions vs 56.2% in the 40 before (0.94x); shares delivered per day 0.88x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 29 May 25Results Q4 FY25 results: net profit −₹2.8 cr -6.6% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Mar 2025 | ₹135 cr | ₹-3 cr | — | -14.5% | -0.02 |
| Mar 2022 | ₹103 cr | ₹23 cr | — | 2.1% | 0.25 |
Shareholding trend
| Holder | Dec 2025 | Jun 2025 |
|---|---|---|
| Promoters | 14.20% | 14.20% |
| Foreign institutions (FII) | 0.28% | 0.38% |
| Domestic institutions (DII) | 0.00% | 0.00% |
| Mutual funds | — | — |
| Retail investors | 67.84% | 67.15% |
| Number of shareholders | 7,95,499 | 8,20,405 |
Common questions
What was Vikas Lifecare Limited's latest quarterly profit?
Vikas Lifecare Limited reported a net loss of ₹3 cr for the quarter ended Mar 2025, on revenue of ₹135 cr.
How much do promoters hold in Vikas Lifecare Limited?
Promoters held 14.20% of Vikas Lifecare Limited at the end of Dec 2025, with 0.03% of promoter shares pledged.
Is Vikas Lifecare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.19.
What is the 52-week high and low of Vikas Lifecare Limited?
The 52-week high is ₹2.09 and the 52-week low is ₹1.05.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Vikas Lifecare Limited | ₹1.11 | ₹206 cr | — | — | 3.4% | -9.2% | 0.19 | -47.1% |
| Shankar Lal Rampal Dye-Chem Ltd. | ₹39.5 | ₹250 cr | 13.7 | — | 11.6% | 16.8% | 0.21 | -42.5% |
| Surana Telecom & Power Ltd. | ₹15.02 | ₹208 cr | 6.2 | — | 14.7% | -1.8% | 0.37 | -31.3% |
| Aprameya Engineering Limited | ₹102.05 | ₹194 cr | 38.1 | — | 7.6% | 14.7% | 0.1 | -62.6% |
| Sicagen India Limited | ₹48.54 | ₹192 cr | 9.4 | — | 3.7% | 5.8% | 0.32 | +90.4% |
| ABans Enterprises Ltd. | ₹26.79 | ₹188 cr | 5.8 | — | 1.9% | -39.7% | 0.75 | -0.8% |
Compare VIKASLIFE with SRD in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open VIKASLIFE in NSE Scanner →